Home › Funds › Redmile Group, LLC › ORIC

Redmile Group, LLC position in ORIC

ORIC PHARMACEUTICALS INC · Health Care

Redmile Group, LLC reported holding 362,010 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$3.9M, representing 0.26% of its reported portfolio and ranking #36 among its reported holdings. Redmile Group, LLC has disclosed ORIC holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)362.01K sh
Reported value held$3.92M
Portfolio Weight0.26%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Redmile Group, LLC's ORIC position evolved

Redmile Group, LLC first disclosed a stake in ORIC in Q4 2025 at 448,110 shares (US$3.7M). The position peaked in Q1 2026 at 415,710 shares, worth US$5.3M. Across 3 filings, Redmile Group, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 362,010 shares valued at US$3.9M — a reduction of -53,700 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 448.11K $3.67M New
Q1 2026 415.71K $5.27M Reduce
Q2 2026 362.01K $3.92M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORIC and 13F data

ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORIC

All ORIC fund holders →

FAQ

How long has Redmile Group, LLC held ORIC?

Redmile Group, LLC has disclosed ORIC holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Redmile Group, LLC's current position in ORIC?

As of Q2 2026, Redmile Group, LLC holds 362.01K shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $3.92M, representing 0.26% of its reported portfolio and ranking #36.

Has Redmile Group, LLC been buying or selling ORIC?

In the latest 13F filing (Q2 2026), Redmile Group, LLC reduced its position in ORIC. The position peaked in Q1 2026 at 415.71K shares.

Which other funds hold ORIC?

Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.